SCHEMBL4100176

SCHEMBL4100176

COCOc1ccc(OC)cc1C(=O)c1ccc(O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.64
HTT P42858 2/20 0.64
NPSR1 Q6W5P4 1/20 0.64
ALDH1A1 P00352 6/20 0.58
POLB P06746 1/20 0.57
NPC1 O15118 1/20 0.51
CYP2C9 P11712 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
HPGD P15428 3/20 0.50
KDM4E B2RXH2 3/20 0.50
LMNA P02545 2/20 0.50
MAPK1 P28482 2/20 0.50
CYP3A4 P08684 1/20 0.50
RECQL P46063 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CYP1A2 P05177 1/20 0.49
PGR P06401 1/20 0.49
CYP2D6 P10635 1/20 0.49
SLC6A2 P23975 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4091547 0.90 NPC1 (0.64) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL8129088 0.89 ALDH1A1 (0.74) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL23409046 0.88 MAPT (0.61) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL30070804 0.88 MAPT (0.61) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL8136548 0.87 MAPT (0.61) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL8133226 0.86 MAPT (0.59) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL8134039 0.86 MAPT (0.59) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL4092308 0.85 HTT (0.56) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL21483267 0.83 LMNA (0.51) MAPTHTTNPSR1ALDH1A1POLB
SCHEMBL30070845 0.83 LMNA (0.51) MAPTHTTNPSR1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054435-A1 Phenoxyalkanoic Acid Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-02-26 US disclosed
EP-1911738-A1 PHENOXYALKANOIC ACID COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054435-A1 Phenoxyalkanoic Acid Compound PNLIP, GPR119, LIPC MAPT 3533/4885HTT 1222/4885NPSR1 2804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.